Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation

Clinical Transplantation

Volumn 22, Issue 5, 2008, Pages 651-656

  Brandão, Ajacio ^a,b,c   Fuchs, Sandra C ^b   Gleisner, Ana L ^a,b   Marroni, Claudio ^a,c   Zanotelli, Maria L ^a,b   Cantisani, Guido ^a,b  

^a Liver Transplantation Group   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Liver transplantation; Model for endstage liver disease; Outcome

Indexed keywords

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAZIL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; BRAZIL; COHORT STUDIES; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ODDS RATIO; ROC CURVE; SEVERITY OF ILLNESS INDEX; WAITING LISTS; YOUNG ADULT;

EID: 52649141578     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00860.x     Document Type: Article

References (35)

1. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001: 33: 464.
2. Wiesner RH, McDiarmid SV, Kamath PS et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001: 7: 567.
3. Wiesner R, Edwards E, Freeman R Jr et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003: 124: 91.
4. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease predicts mortality across a broad spectrum of liver disease. J Hepatol 2004: 40: 897.
5. Shet M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterology 2002: 2: 2.
6. Srikujera W, Kyulo NL, Runyon BA, Hu K-Q. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005: 42: 700.
7. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int 2004: 24: 1.
8. Brasil. Ministério da Saúde. Secretaria de Assistência àSaúde. Portaria GM n° 3.407 de 5 de agosto de 1998. Diário Oficial da União n° 149, Brasília, 6 de agosto de 1998.
9. Brasil. Ministério da Saúde. Secretaria de Assistência àSaúde. Portaria GM n° 1.160 de 29 de maio de 2006. Diário Oficial da União n° 103, Brasília, 31 de maio de 2006.
10. Teixeira AC, Souza FF, Mota GA, Martinelli AL, Sankarankutty AK, Silva OC. Liver transplantation. Expectations with MELD score for liver allocation in Brazil. Acta Cir Bras 2006: 21(Suppl. 1): 12.
11. Kamath PS, Kim WR. The model for end-stage liver disease. Hepatology 2007: 45: 797.
12. Pugh RWH, Murray-Lyon IM, Dawson JL. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973: 60: 646.
13. De Rave S. EMERALD - better than MELD? Proceedings of the 39th Annual Meeting of the European Association for the Study of the Liver, April 14-18, 2004, Berlin, Germany. Amsterdam: Elsevier, 2004.
14. De Rave S. Heterotopic and orthotopic liver transplantation in man. Studies on outcome and predictive models Thesis. Rotterdam, the Netherlands: Erasmus Universiteit Rotterdam, 2005.
15. Schiff ER, Sorrel MF, Maddrey WC. Schiff′s Diseases of the Liver, 8th edn. Philadelphia: Lippincott-Raven Publishers, 1999.
16. Bruix J, Sherman M, Llovet JM et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001: 35: 421.
17. Habib S, Berk B, Chang C-C et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006: 12: 440.
18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982: 143: 29.
19. De Long ER, De Long DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: A nonparametric approach. Biometrics 1988: 44: 837.
20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983: 148: 839.
21. LladóL, Figueras J, Memba R et al. Is MELD really the definitive score for liver allocation? Liver Transpl 2002: 8: 795.
22. Foxton MR, Kendrick S, Sizer E et al. The model for end-stage liver disease (MELD) score while awaiting liver transplant predicts long-term outcome from liver transplantation [abstract]. Hepatology 2004: 40(Suppl. 1): 549A.
23. Burak KW, Meeberg G, Myers RP et al. Should Canada adopt the MELD score for allocation of liver transplants [Abstract]? Hepatology 2005: 42(Suppl. 1): 322A.
24. Botta F, Giannini E, Romagnoli P et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: A European study. Gut 2003: 52: 134.
25. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther 2004: 21: 169.
26. Yoo HY, Thuluvath PJ. Short-term post liver transplant survival after introduction of MELD scores for organ allocation in the United States. Liver Int 2005: 25: 536.
27. W iesner RH. Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl 2005: 11: 261.
28. Freeman RB Jr, Wiesner RH, Edwards E et al. Results of the first year of the new allocation plan. Liver Transpl 2004: 10: 7.
29. Kim W, Kremers W, Malinchoc M, Rosen C, Dickson ER. Determinants of death on liver transplant waiting list: Waiting time, blood group, or MELD [abstract]? Hepatology 2001: 34: 204A.
30. Huo T-I, Wu J-C, Lin H-C et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: Risk factors analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005: 42: 826.
31. Huo T-I, Lin H-C, Wu J-C et al. Different model for end-stage liver disease score block distribution may have a variable ability for outcome prediction. Transplantation 2005: 80: 1414.
32. Deicher SR. International normalized ratio in patients with liver disease. Lancet 2002: 359: 47.
33. Kovacs M. International normalized ratio and liver impairment [Letter]. Lancet 2002: 359: 1695.
34. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006: 6: 783.
35. Avolio AW, Gasbarrini AS, Barbarino R et al. Allocation for nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? Transplant Proc 2006: 38: 3567.